Image for Enhansa®
Enhansa®

Related Terms

  • Content available for subscribers only.

Background

  • Enhansa®, manufactured by Lee Silsby Compounding Pharmacy, is a dietary supplement that contains enhanced-absorption curcumin as the active ingredient. It is available as capsules or a powder and is designed to be taken once or twice daily.
  • Curcumin, the compound responsible for the bright yellow color of turmeric (Curcuma longa), is believed to be the principal pharmacological agent.
  • In general, evidence from human and animal studies suggests that curcumin may be poorly absorbed into the bloodstream. The manufacturer claims that Enhansa® may be 7-8 times more absorbable than standard curcumin extracts.
  • The manufacturer also claims that curcumin may help treat autism spectrum disorders (ASDs) because it reduces the levels of inflammatory markers and other chemicals usually elevated in such diseases. According to the manufacturer, curcumin may increase levels of glutathione, which may be decreased in people with autism or other developmental disorders.
  • Further content available for subscribers only.

Theory/Evidence

  • Content available for subscribers only.

Dosing

  • Content available for subscribers only.

Safety

  • Content available for subscribers only.

Author Information

  • Content available for subscribers only.

References

Natural Standard developed the above evidence-based information based on a thorough systematic review of the available scientific articles. For comprehensive information about alternative and complementary therapies on the professional level, go to www.naturalstandard.com. Selected references are listed below.

  • Content available for subscribers only.
The information in this monograph is intended for informational purposes only, and is meant to help users better understand health concerns. Information is based on review of scientific research data, historical practice patterns, and clinical experience. This information should not be interpreted as specific medical advice. Users should consult with a qualified healthcare provider for specific questions regarding therapies, diagnosis and/or health conditions, prior to making therapeutic decisions.